72.11 — Research and experimental development on biotechnology
NACE Rev. 2 72.11 (Research and experimental development on biotechnology) classifies within economic division 72 (NACE Rev), linking EU/UN activity boundaries with US NAICS, UK SIC, and national regulatory obligations.
Eurostat • v2.0
Research and experimental development on natural sciences and engineering
NAICS 541713 • SIC 72110
MCC 8731
Activity Scope, Operators & Exclusions
Who Uses This Code & Typical Business Models
- Biotech, pharma discovery, AI/quantum, materials, and engineering R&D firms (72.10)
- Contract Research Organizations (CROs), university spinouts, and deep-tech labs
- Social sciences, humanities, and policy research institutes (72.20)
This Class Includes
7- DNA/RNA: genomics, pharmacogenomics, gene probes, genetic engineering, DNA/RNA sequencing/synthesis/amplification, gene expression profiling, and use of antisense technology
- proteins and other molecules: sequencing/synthesis/engineering of proteins and peptides (including large molecule hormones); improved delivery methods for large molecule drugs; proteomics, protein isolation and purification, signalling, identification of cell receptors
- cell and tissue culture and engineering: cell/tissue culture, tissue engineering (including tissue scaffolds and biomedical engineering), cellular fusion, vaccine/immune stimulants, embryo manipulation
- process biotechnology techniques: fermentation using bioreactors, bioprocessing, bioleaching, biopulping, biobleaching, biodesulphurisation, bioremediation, biofiltration and phytoremediation
- gene and RNA vectors: gene therapy, viral vectors
- bioinformatics: construction of databases on genomes, protein sequences; modelling complex biological processes, including systems biology
- nanobiotechnology: applies the tools and processes of nano/microfabrication to build devices for studying biosystems and applications in drug delivery, diagnostics etc.
This Class Excludes (Cross-References)
0—
Legislation, Licensing, Incorporation & Tax Framework
Governing Statutes & Regulations
Mandatory Permits, Licenses & Authorities
- No license required for desk/theoretical R&D; Law 5746 R&D Center certification requires 15–30+ FTE researchers inside dedicated facilities.
- Clinical trials (CROs) require TİTCK Clinical Research Approval; genetic/biosafety labs follow Law No. 5977 & Biosafety regulations.
Incorporation Route & Chamber Registration
- EU NACE Rev. 2.1 Framework
- NACE Rev. 2.1 merged 72.11 Biotech & 72.19 into unified 72.10! EU entities access Horizon Europe grants, OECD Frascati Manual R&D standards, and Clinical Trials Reg. (EU) 536/2014.
- United States (IRS / SBA / NAICS)
- Maps to NAICS 5417. Deep-tech labs tap federal SBIR/STTR non-dilutive grants and IRS IRC § 41 R&D Tax Credit (allowing eligible startups up to $500k/yr payroll-tax offset alongside § 174 rules).
- United Kingdom (Companies House / HMRC)
- Directly unlocks UK R&D Intensive SME Relief (ERIS) cash tax credits, the 10% UK Patent Box, and Innovate UK grants under UK SIC 72xxx.
VAT, Withholding & Statutory Incentives
- MAXIMUM TAX RELIEF STACK: Eligible R&D spending unlocks 100% Super-Deduction + 80–95% Payroll Income-Tax Withholding Relief + 50% SGK Employer Share subsidy under Law 5746, plus Teknokent Law 4691 100% profit exemption and 50% Patent Box exemption (KVK Art. 5/B)!
- Eligible for KOSGEB Business Development (1.5M+ TL) and TÜBİTAK TEYDEB / 1512 BİGG non-dilutive R&D grants.
Cross-Border Regulatory Frameworks (EU / US / UK)
Chamber of Commerce or Industry — Corporate entity standard for R&D grants, patent ownership, and VC equity.
NACE Rev. 2.1 merged 72.11 Biotech & 72.19 into unified 72.10! EU entities access Horizon Europe grants, OECD Frascati Manual R&D standards, and Clinical Trials Reg. (EU) 536/2014.
Classification Boundaries & Audit Risks
- Routine QA/certification testing belongs in 71.20, and commercial market polling sits in 73.20 — NOT Div. 72 R&D.
- Commercializing an invented product into mass manufacturing requires adding the applicable Div. 10–32 production code alongside R&D.
Global Classification Passport
Verified structural and concordance mappings across EU, US, UK, UN, and national registries.
Research and Development in Biotechnology (except Nanobiotechnology)
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Payment Processing & ISO 18245 MCC Profile
Visa / Mastercard ISO 18245Low-risk B2B laboratory, certification, and contract R&D billing.
Critical Distinctions & Sibling Codes
Critical Regulatory & Scope Boundaries vs. Adjacent Codes
| Compared Code | Scope Boundary | Regulatory & Tax Impact |
|---|---|---|
| 62.10 — Software Engineering → | Fundamental experimental science/deep-tech discovery is 72.10; commercial software app delivery is 62.10. | Both enjoy high-tech priority; wet labs trigger biosafety/clinical approvals. |
72.19 — Other research and experimental development on natural sciences and engineering
Official NACE Rev. 2 (Legacy) code 72.19: research and experimental development on natural science and engineering other than biotechnological research and experimental development:
72.20 — Research and experimental development on social sciences and humanities
Official NACE Rev. 2 (Legacy) code 72.20: research and development on social sciences
Classification Hierarchy & Data Export
- M Professional, scientific and technical activities
- 72 Scientific research and development
- 72.1 Research and experimental development on natural sciences and engineering
- 72.11 Research and experimental development on biotechnology
Frequently Asked Questions
What business activities and models fall under NACE Rev. 2 72.11?
72.11 (Research and experimental development on biotechnology): DNA/RNA: genomics, pharmacogenomics, gene probes, genetic engineering, DNA/RNA sequencing/synthesis/amplification, gene expression profiling, and use of antisense technology; proteins and other molecules: sequencing/synthesis/engineering of proteins and peptides (including large molecule hormones); improved delivery methods for large molecule drugs; proteomics, protein isolation and purification, signalling, identification of cell receptors; cell and tissue culture and engineering: cell/tissue culture, tissue engineering (including tissue scaffolds and biomedical engineering), cellular fusion, vaccine/immune stimulants, embryo manipulation. Typical operators: Biotech, pharma discovery, AI/quantum, materials, and engineering R&D firms (72.10); Contract Research Organizations (CROs), university spinouts, and deep-tech labs.
What regulatory licensing and tax rules apply to 72.11 across EU, US, UK, or Turkey?
EU: NACE Rev. 2.1 merged 72.11 Biotech & 72.19 into unified 72.10! EU entities access Horizon Europe grants, OECD Frascati Manual R&D standards, and Clinical Trials Reg. (EU) 536/2014. US: Maps to NAICS 5417. Deep-tech labs tap federal SBIR/STTR non-dilutive grants and IRS IRC § 41 R&D Tax Credit (allowing eligible startups up to $500k/yr payroll-tax offset alongside § 174 rules). UK: Directly unlocks UK R&D Intensive SME Relief (ERIS) cash tax credits, the 10% UK Patent Box, and Innovate UK grants under UK SIC 72xxx.
How does 72.11 differ legally from 62.10 (62.10 — Software Engineering)?
Fundamental experimental science/deep-tech discovery is 72.10; commercial software app delivery is 62.10. Regulatory impact: Both enjoy high-tech priority; wet labs trigger biosafety/clinical approvals.
What are the international classification equivalents and MCC code for 72.11?
Verified concordance for 72.11: US NAICS 2022: 541713 (Research and Development in Nanotechnology), 541714 (Research and Development in Biotechnology (except Nanobiotechnology)), 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)) • UK SIC 2007: 72110 (Research and experimental development on biotechnology) • Payment MCC 8731 (Testing Laboratories (Non-Medical) & R&D).
What replaces legacy NACE Rev. 2 code 72.11 in NACE Rev. 2.1?
In the 2025–2026 NACE Rev. 2.1 revision, 72.11 transitions to 72.10 (Research and experimental development on natural sciences and engineering).